2,830
Participants
Start Date
June 30, 2003
Primary Completion Date
October 31, 2007
Study Completion Date
December 31, 2025
Documentation
Participants will receive written educational material for themselves as well as the Guidelines document for their physician (same written material as in the Educational Video Group). They will be asked to revisit their physician and provide written documentation inviting him/her to consider a complementary investigation and an adequate treatment according to the 2002 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada
Video
Participants will receive a 15-minute educational video on osteoporosis. They will also receive written educational material for themselves and a Guidelines document for their physician. They will be asked to revisit their physician and provide the written documentation inviting her/him to consider a complementary investigation and an adequate treatment according to the 2002 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada. Should participants wish to obtain additional information on osteoporosis, they will be provided with a toll-free number (1-866-571-ROCQ) to contact
CHUdeQuebec, CHUL, Québec
Merck Frosst Canada Ltd.
INDUSTRY
Sanofi
INDUSTRY
Procter and Gamble
INDUSTRY
Amgen
INDUSTRY
Eli Lilly and Company
INDUSTRY
Novartis
INDUSTRY
CHU de Quebec-Universite Laval
OTHER